Laurent Meijer
Roscoff, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 125 publications
Ciliogenesis associated kinase 1 accumulates in its inactive form during polycystic kidney disease progression.
Journal: bioRxiv : the preprint server for biology
Published: May 25, 2026
DYRK1A and Parkinson's disease, facts and hypotheses.
Journal: Neurobiology of disease
Published: March 13, 2026
Promoting Research Excellence in Down Syndrome: Proceedings of the 5th International Conference of the Trisomy 21 Research Society.
Journal: Neuromolecular medicine
Published: March 13, 2026
Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 iPSC-derived neural cells.
Journal: bioRxiv : the preprint server for biology
Published: February 12, 2026
Mapping the Brain Interaction Network of the Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Targeted by Leucettinib-21 Using Affinity Chromatography.
Journal: ACS pharmacology & translational science
Published: February 04, 2026
Nitrogen-Doped Graphene Quantum Dots Conjugated to Leucettinib-21 Rescue Differentiating Zebrafish Purkinje Cells by Inhibiting Dyrk1A Kinase.
Journal: ACS applied nano materials
Published: January 16, 2026
Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 induced pluripotent stem cell-derived neural cells.
Journal: Disease models & mechanisms
Published: November 04, 2025
Network Modeling Predicts How DYRK1A Inhibition Promotes Cardiomyocyte Cycling after Ischemic/Reperfusion Injury.
Journal: bioRxiv : the preprint server for biology
Published: September 03, 2025
Restoring amyloid-β42 and γ-secretase function in Alzheimer's disease.
Journal: Brain : a journal of neurology
Published: May 23, 2025
Use of microbiome analysis as a complementary endpoint in clinical trials.
Journal: iScience
Published: April 28, 2025
Last Updated: 09/26/2026